AKEBIA THERAPEUTICS, INC. (AKBA)

0.88 -6.49% (-0.06)

Over 3Y: -29.7%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

1 2 3 4
2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Income: -54.9M Q3 '21 — Operating Cash Flow: -56.3M Q3 '21 — Free Cash Flow: -56.3M Q3 '21 — Net Income: -59.5M Q4 '21 — Operating Income: -65.3M Q4 '21 — Operating Cash Flow: -62.8M Q4 '21 — Free Cash Flow: -62.8M Q4 '21 — Net Income: -69.9M Q1 '22 — Operating Income: -59.6M Q1 '22 — Operating Cash Flow: -21.6M Q1 '22 — Free Cash Flow: -21.7M Q1 '22 — Net Income: -63.5M Q2 '22 — Operating Income: 34.1M Q2 '22 — Operating Cash Flow: -30.7M Q2 '22 — Free Cash Flow: -30.7M Q2 '22 — Net Income: 29.4M Q3 '22 — Operating Income: -50.4M Q3 '22 — Operating Cash Flow: 33.8M Q3 '22 — Free Cash Flow: 33.8M Q3 '22 — Net Income: -54.1M Q4 '22 — Operating Income: -4.9M Q4 '22 — Operating Cash Flow: -54.7M Q4 '22 — Free Cash Flow: -54.7M Q4 '22 — Net Income: -6.1M Q1 '23 — Operating Income: -25.6M Q1 '23 — Operating Cash Flow: -17.5M Q1 '23 — Free Cash Flow: -17.5M Q1 '23 — Net Income: -26.9M Q2 '23 — Operating Income: -9M Q2 '23 — Operating Cash Flow: 3.6M Q2 '23 — Free Cash Flow: 3.6M Q2 '23 — Net Income: -11.2M Q3 '23 — Operating Income: -13M Q3 '23 — Operating Cash Flow: -7.2M Q3 '23 — Free Cash Flow: -7.2M Q3 '23 — Net Income: -14.5M Q4 '23 — Operating Income: 1.4M Q4 '23 — Operating Cash Flow: -2.3M Q4 '23 — Free Cash Flow: -2.3M Q4 '23 — Net Income: 614K Q1 '24 — Operating Income: -14.9M Q1 '24 — Operating Cash Flow: -19.4M Q1 '24 — Free Cash Flow: -19.4M Q1 '24 — Net Income: -18M Q2 '24 — Operating Income: -8.7M Q2 '24 — Operating Cash Flow: -10.1M Q2 '24 — Free Cash Flow: -10.1M Q2 '24 — Net Income: -8.6M Q3 '24 — Operating Income: -12.5M Q3 '24 — Operating Cash Flow: -6.7M Q3 '24 — Free Cash Flow: -6.7M Q3 '24 — Net Income: -20M Q4 '24 — Operating Income: -14.3M Q4 '24 — Operating Cash Flow: -4.5M Q4 '24 — Free Cash Flow: -4.5M Q4 '24 — Net Income: -22.8M Q1 '25 — Operating Income: 13.5M Q1 '25 — Operating Cash Flow: -13.6M Q1 '25 — Free Cash Flow: -13.6M Q1 '25 — Net Income: 6.1M Q2 '25 — Operating Income: 14.1M Q2 '25 — Operating Cash Flow: 22.3M Q2 '25 — Free Cash Flow: 22.2M Q2 '25 — Net Income: 247K Q3 '25 — Operating Income: 4.4M Q3 '25 — Operating Cash Flow: 28.1M Q3 '25 — Free Cash Flow: 28M Q3 '25 — Net Income: 540K Q4 '25 — Operating Cash Flow: 31.1M Q4 '25 — Free Cash Flow: 31.1M Q1 '26 — Operating Income: -4.7M Q1 '26 — Operating Cash Flow: -21.2M Q1 '26 — Free Cash Flow: -21.3M Q1 '26 — Net Income: -9.1M Q2 '26 — Operating Income: -6.3M Q2 '26 — Operating Cash Flow: 3.5M Q2 '26 — Free Cash Flow: 2.4M Q2 '26 — Net Income: -8.9M -50M -25M 0 25M 50M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Operating Income Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

6.0
ROIC —
OE margin 12.3%
Oper. margin 10.7%
Accruals -13.4%
Gross margin 79.6%
FCF margin 18.4%
OCF / EBIT 1.8×
OCF margin 19.0%
ROCE 12.4%
ROA -1.5%
ROE -21.4%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.2
RPO / sales 0.028×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

4.7
ND/EBITDA —
Cash / Debt 2.1×
Debt payback 0.0 yr
Quick ratio 1.3×
F-score 6.0 pts
Debt / Eq 3.0×
Cash runway —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.8
Sales/sh Y/Y -11.8%
Sales Q/Q -21.4%
Shares change +21.9%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.